{"id":3010,"date":"2017-06-30T06:30:00","date_gmt":"2017-06-30T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/"},"modified":"2017-06-30T06:30:00","modified_gmt":"2017-06-30T06:30:00","slug":"forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/","title":{"rendered":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion"},"content":{"rendered":"<p><span>Till f\u00f6ljd av utnyttjande av teckningsoptioner har antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) under juni 2017 \u00f6kat med 215\u00a0000 aktier och r\u00f6ster. Per den 30 juni 2017 finns d\u00e4rmed sammanlagt 26 190 496 aktier och r\u00f6ster i bolaget.<\/span><\/p>\n<p><span>G\u00f6teborg 30 juni 2017<br \/> Christoffer Rosenblad, CFO<br \/><\/span>XVIVO Perfusion AB (publ)<\/p>\n<div class=\"mfn-footer\">\n<p><span>F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, +1\u00a0720\u00a0616 2101, christoffer.rosenblad@xvivoperfusion.com<br \/>Magnus Nilsson, VD, +46 31-788 21 50, magnus.nilsson@xvivoperfusion.com<\/span><\/p>\n<p><span>F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/span><\/p>\n<p><span>Denna information \u00e4r s\u00e5dan information som Xvivo Perfusion AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt lagen om handel med finansiella instrument. Informationen l\u00e4mnades f\u00f6r offentligg\u00f6rande klockan 8.30 den 30 juni 2017.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Till f\u00f6ljd av utnyttjande av teckningsoptioner har antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) under juni 2017 \u00f6kat&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3010","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ca-shares","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-lhfi","mfn-news-tag-mfn-ca"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Till f\u00f6ljd av utnyttjande av teckningsoptioner har antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) under juni 2017 \u00f6kat...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\\\/\",\"name\":\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2017-06-30T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/","og_locale":"en_US","og_type":"article","og_title":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","og_description":"Till f\u00f6ljd av utnyttjande av teckningsoptioner har antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) under juni 2017 \u00f6kat...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/","name":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2017-06-30T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}